HUP0000362A2 - Madár-reovírusok új antigén osztálya - Google Patents

Madár-reovírusok új antigén osztálya

Info

Publication number
HUP0000362A2
HUP0000362A2 HU0000362A HUP0000362A HUP0000362A2 HU P0000362 A2 HUP0000362 A2 HU P0000362A2 HU 0000362 A HU0000362 A HU 0000362A HU P0000362 A HUP0000362 A HU P0000362A HU P0000362 A2 HUP0000362 A2 HU P0000362A2
Authority
HU
Hungary
Prior art keywords
avian reoviruses
novel antigenic
antigenic class
class
reoviruses
Prior art date
Application number
HU0000362A
Other languages
English (en)
Inventor
Adriaan A.W.M. Van Loon
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HU0000362D0 publication Critical patent/HU0000362D0/hu
Publication of HUP0000362A2 publication Critical patent/HUP0000362A2/hu
Publication of HUP0000362A3 publication Critical patent/HUP0000362A3/hu
Publication of HU225434B1 publication Critical patent/HU225434B1/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/15Reoviridae, e.g. calf diarrhea virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12211Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A találmány szárnyasokban az enteriális betegségi állapotoklétrejöttében szerepet játszó madárreovírusok egy új antigénosztályáravonatkozik. A találmány tárgyát képezi továbbá egy vakcina szárnyasokvédelmére ilyen betegségi állapotokkal szemben, melyek az új típusúmadárreovírusoktól származnak. Ó
HU0000362A 1999-01-29 2000-01-28 Avian reoviruses belonging to an novel antigenic class of avian reoviruses HU225434B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200259 1999-01-29

Publications (4)

Publication Number Publication Date
HU0000362D0 HU0000362D0 (en) 2000-04-28
HUP0000362A2 true HUP0000362A2 (hu) 2000-11-28
HUP0000362A3 HUP0000362A3 (en) 2005-04-28
HU225434B1 HU225434B1 (en) 2006-11-28

Family

ID=8239847

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000362A HU225434B1 (en) 1999-01-29 2000-01-28 Avian reoviruses belonging to an novel antigenic class of avian reoviruses

Country Status (16)

Country Link
US (1) US6951650B1 (hu)
EP (1) EP1024189B1 (hu)
JP (2) JP4659942B2 (hu)
KR (1) KR100583259B1 (hu)
AT (1) ATE292674T1 (hu)
AU (1) AU759179B2 (hu)
BR (1) BR0000190A (hu)
CA (1) CA2297345C (hu)
DE (1) DE60019178T2 (hu)
ES (1) ES2240005T3 (hu)
HU (1) HU225434B1 (hu)
MX (1) MXPA00001001A (hu)
PL (1) PL192277B1 (hu)
PT (1) PT1024189E (hu)
RU (1) RU2265659C2 (hu)
ZA (1) ZA200000370B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1700929A (zh) * 2002-09-16 2005-11-23 惠氏公司 含有禽吸收障碍综合征相关病毒的疫苗及其给药方法
AU2003296912A1 (en) * 2002-10-09 2004-05-04 Akzo Nobel N.V. Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics
WO2008076518A2 (en) * 2006-10-25 2008-06-26 University Of Georgia Research Foundation, Inc. Reovirus compositions and methods of use
EP2304024A2 (en) 2008-06-26 2011-04-06 Biomune Company Avian reoviridae
WO2010059899A2 (en) * 2008-11-20 2010-05-27 University Of Georgia Research Foundation, Inc. Vaccine for runting-stunting syndrome
CA2725435C (en) * 2009-12-15 2023-01-03 University Of Saskatchewan Vaccines for inclusion body hepatitis
KR101600959B1 (ko) 2013-06-18 2016-03-08 단국대학교 산학협력단 가금 레오바이러스 시그마 c 단백질의 항원 결정기를 포함하는 재조합 단백질 및 이에 대한 항체
JP6682441B2 (ja) * 2014-01-29 2020-04-15 ユニバーシティ オブ ジョージア リサーチ ファンデーション,インコーポレーテッド トリレオウイルスワクチン
EP3200820B1 (en) 2014-10-03 2023-07-05 Intervet International B.V. Broad-spectrum vaccine against avian reovirus
CN104711240B (zh) * 2015-03-18 2017-10-10 广西壮族自治区兽医研究所 禽呼肠孤病毒σA蛋白及其相关生物材料的应用
US11541111B2 (en) 2016-01-07 2023-01-03 Gavish-Galilee Bio Applications, Ltd. Optimized polypeptide for a subunit vaccine against avian reovirus
CN108794627A (zh) * 2018-07-03 2018-11-13 重庆永健生物技术有限责任公司 一种鸭呼肠孤病毒精制卵黄抗体的制备方法
CN111000992A (zh) * 2019-12-19 2020-04-14 广州渔跃生物技术有限公司 一种鸭呼肠孤病毒、鸭坦布苏病毒和鸭腺病毒三联灭活疫苗及其制备方法
CN116478937B (zh) * 2023-06-12 2023-08-18 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 基因iii型禽呼肠孤病毒变异株及其在制备疫苗中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559229A (en) * 1982-07-20 1985-12-17 Research Foundation Avian proventriculitis vaccine
US5525342A (en) * 1994-05-20 1996-06-11 Akzo Nobel, N.V. Reovirus strain 2177 and vaccine containing same

Also Published As

Publication number Publication date
ATE292674T1 (de) 2005-04-15
HUP0000362A3 (en) 2005-04-28
DE60019178T2 (de) 2005-09-08
RU2265659C2 (ru) 2005-12-10
PL338118A1 (en) 2000-07-31
KR20010069166A (ko) 2001-07-23
JP2000295986A (ja) 2000-10-24
EP1024189B1 (en) 2005-04-06
AU1362900A (en) 2000-08-03
ZA200000370B (en) 2000-08-07
CA2297345A1 (en) 2000-07-29
CA2297345C (en) 2010-07-13
DE60019178D1 (de) 2005-05-12
PL192277B1 (pl) 2006-09-29
BR0000190A (pt) 2001-08-21
US6951650B1 (en) 2005-10-04
HU225434B1 (en) 2006-11-28
EP1024189A1 (en) 2000-08-02
PT1024189E (pt) 2005-08-31
HU0000362D0 (en) 2000-04-28
ES2240005T3 (es) 2005-10-16
AU759179B2 (en) 2003-04-10
JP4659942B2 (ja) 2011-03-30
JP2011092190A (ja) 2011-05-12
KR100583259B1 (ko) 2006-05-25
MXPA00001001A (es) 2002-03-08

Similar Documents

Publication Publication Date Title
HUP0000362A2 (hu) Madár-reovírusok új antigén osztálya
DE60027029D1 (de) Kombinierte impfstoffzusammensetzungen
DE60009511D1 (de) Nematizide trifluorbutene
MXPA03001789A (es) Composiciones para el cuidado de telas que comprenden silicones cationicos y metodos que emplean las mismas.
ATE265860T1 (de) Impstoff zur behandlung von atherosclerosis
NO20031483D0 (no) Vaksine
BR0209242A (pt) Aminopolidiorganossiloxanos amido-funcionais
IT1316928B1 (it) Perfezionamento ad un attacco per protesi dentarie.
NO20006191D0 (no) Vaksine
DZ3219A1 (fr) Vaccin
DZ2283A1 (fr) Composition de vaccin.
DE60021065D1 (de) Virus behandlung
NO20022333L (no) Ny anvendelse av antistoffer som vaksiner
DE60112671D1 (de) Gebogener, elastischer Zahnregulierungsring
DE60120425D1 (de) Verfahren zur herstellung von klonierten vögeln
NO20023697D0 (no) Cykliske heksapeptidderivater
DE69903252T2 (de) Verfahren zur Herstellung der Taxolanalogen 10-Deacetyltaxol A, B und C
ATE374811T1 (de) Hühner-astrovirus typ 2
ES1044251Y (es) Implante dental.
ATE267598T1 (de) Virus behandlung
DK1176193T3 (da) Hæmmere af virusinfektion, som angriber den n-terminale region af integrase
FI990622A0 (fi) Höyrymoottori
ITSV20010001U4 (it) Vedi invenzione n. 16 del 1998
IT1307070B1 (it) Impianto dentale.
ITBS990085V0 (it) Impianto dentale endosseo.

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: INTERVET INTERNATIONAL B.V., NL

Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL

MM4A Lapse of definitive patent protection due to non-payment of fees